View all veterinary jobs
VetSurgeon.org publishes a curated feed of veterinary news for practising veterinary surgeons, with a primary focus on the UK profession.
We select stories based on their practical relevance, clinical interest, or professional significance — filtering out noise so busy vets can stay informed quickly.
Our coverage includes:
We report across all areas of practice, including companion animal, farm, equine and exotic species.
Our editorial approach is deliberately selective and concise. We prioritise clarity and relevance over volume, aiming to make each story worth your time.
You can follow VetSurgeon News by subscribing to the daily, weekly or monthly email digest, or via our channels on Facebook and LinkedIn.
Willows' Head of Imaging Andrew Parry, an RCVS and European Specialist in Diagnostic Imaging (pictured on the left with Clinical Director, Toby Gemmill), said: "There are very few veterinary hospitals anywhere in the country which would have the case-load or the complexity of cases to justify such a sizeable investment. Additionally, this magnet will bring multiple opportunities for clinical research which could ultimately lead to improvements in animal health."
Andrew added: “To my knowledge, we are the only centre in the UK that has fully replaced a high-field magnet MRI with a complete new solution.
"This is very unusual as scanners tend to be upgraded from a high field to higher field, rather than replaced altogether.
"However, our aim wasn’t to purely upgrade the equipment, it was to have access to the best diagnostic imaging equipment available, in order to ensure high quality images are obtained and interpreted, providing the most accurate and rapid diagnosis for our patients. This can make a significant difference to the level of care we are able to provide for pets."
For more information, visit: willows.uk.net
The Disciplinary Committee of the Royal College of Veterinary Surgeons has directed that the name of a veterinary surgeon who had been practising in Essex be removed from the RCVS Register, having found him guilty of attempting to obtain medicines dishonestly.
James Alexander Lockyear, a graduate from Pretoria University in South Africa, was charged with two offences. The case was heard in his absence, although the Committee did not draw any adverse inference from this. One charge concerned his attempted purchase of steroids from a pharmacy in Colchester by dishonestly representing that the medicine was for legitimate veterinary use. The second charge related to several instances of what the Committee referred to as "inappropriate and unprofessional behaviour", including showing an offensive image to another staff member on a mobile phone, placing the testicle of a castrated dog in his mouth and the misuse of an endotracheal tube.
All of the incidents had taken place between April 2008 and September 2009, while Mr Lockyear was practising as a locum veterinary surgeon at St Runwald's Veterinary Surgery, Colchester, Essex.
The Disciplinary Committee heard evidence from a pharmacist, Mr Noble, to whom Mr Lockyear had presented an incomplete veterinary prescription for 12 ampoules of Sustanon, a prescription-only anabolic steroid for humans, and a further pharmacist, Mr Foskett MRPharmS, who outlined his suspicions that the steroids were in fact for Mr Lockyear's personal use (Sustanon is a substance which can potentially be misused in relation to body-building). Mr Lockyear had originally claimed the drugs were for general stock at the practice; he later returned with a second prescription, for double the amount of Sustanon, claiming it was for his own dog; later again, he said the prescription was for a friend's dog.
The Committee also heard evidence from the veterinary owner of the practice, a veterinary nurse and a student veterinary nurse working in the practice team, and from Dr Maddison MRCVS, an expert on small animal clinical pharmacology. Dr Maddison informed the Committee that there was a veterinary alternative to Sustanon, so it was not necessary for that drug to have been sought by Mr Lockyear. She was also of the view that Sustanon would not have been suitable to treat the ailments for which Mr Lockyear claimed it was to be used.
The Committee found Mr Lockyear guilty of the first charge - that is attempting to obtain medicines dishonestly. Chairing the Disciplinary Committee, Mrs Alison Bruce, said: "Whilst it was a one-off incident, it is conduct which falls far short of that which is expected of a member of the profession. It involves serious dishonesty; it represents an abuse of a veterinary surgeon's authority to prescribe drugs; it is conduct which tends to undermine public trust in the profession, and the honesty of its members; it is conduct which compromised other professionals, the pharmacists involved, and undermined the trust which ought to exist between pharmacists and veterinary surgeons generally, in the important area of drug prescription." The Committee therefore directed that Mr Lockyear's name be removed from the Register.
Regarding the second charge, the Committee was most concerned about the incident relating to the dog's testicles, which it felt offended against Mr Lockyear's duty to treat with respect all animals which were his patients. Taking the three incidents as a whole, the Committee felt that Mr Lockyear should be seriously criticised for behaviour that was "unprofessional... juvenile, inappropriate, disgusting and offensive". However, they felt that the conduct was not malicious, and did not occur in the presence of a member of the public, so concluded that this did not amount to disgraceful conduct in a professional respect.
BCF Technology has launched a new series of CPD videos on VetSurgeon.org, this time showing how to conduct a basic cardiac ultrasound examination in small animals. The videos are followed by a short online quiz.
BCF in-house vet Kimberly Palgrave BS BVM&S GPCert(DI) MRCVS presents a series of free online instructional step-by-step videos demonstrating how to perform a basic cardiac ultrasound examination in the general practice setting.
These 3-5 minute videos, which were produced in collaboration with The Royal (Dick) School of Veterinary Studies, also cover how to alter the controls on your ultrasound machine to get the most from your equipment.
The cardiac ultrasound videos follow the very popular series of videos created by BCF on scanning the small animal abdomen last year. The abdominal videos have had in total over 25,000 views on YouTube so far.
Kimberly Palgrave said: "Following some fantastic feedback on the abdominal ultrasound videos, we decided to produce this series of basic echocardiography videos. People were asking for help with cardiac examinations and we were happy to help. Please do let us know what you think and what you would like us to cover next."
Gavin Mitchell from BCF said: "We are committed to helping you learn more to ensure you and your team get the very best from your ultrasound equipment. These videos are just one way that BCF contribute to veterinary learning. We run and support training courses and we can also arrange for a member of our team to come into your practice and provide a day of training. At BCF we do so much more than just sell ultrasound and X-ray kit. We strive to help you learn how to use your diagnostic imaging equipment and support you with advice, technical back-up, service and repair."
To see the new cardiac ultrasound videos visit the BCF Technology Gallery here on VetSurgeon.org. Complete the short online quiz at the end, and you will also receive a CPD certificate.
For more information, or to arrange a demo for your veterinary practice, call +44 (0)1506 460 023.
The RSPCA is asking veterinary surgeons to take part in a new survey which aims to build a true picture of the scale of the problem of illegally imported puppies being brought into the UK.
Amongst other things, the survey asks what you consider to be the greatest concerns regarding the poor breeding, dealing and illegal import of puppies and what you think can be done to tackle these and the associated problems.
You can take part in the survey here: www.surveymonkey.com/s/QQNBVFV
James Yeates, Chief Veterinary Officer, said: "RSPCA intelligence suggests that there is a growing illegal trade in puppies from other EU countries and is causing serious health and welfare problems. In many cases puppies are dying or becoming seriously ill. Risk factors appear to include being taken from their mothers too early, not being vaccinated and having to endure long journeys in poor conditions.
"However, it's very difficult to get a full view on the scale of the problem as many cases never get reported to the RSPCA. Vets are likely to be the first port of call when a puppy bought by an unsuspecting buyer becomes sick and may be faced with many of these cases - if sadly not all.
"We're interested in hearing from vets to get their evidence from practice and to hear their ideas about how we can tackle the lucrative illegal trade in puppies."
The company says the like-for-like sales increase was at the upper end of its target of between 4% and 8%, and that it continues to see resilience in the veterinary sector, with membership of its Healthy Pet Club preventative healthcare scheme increasing in the year by 19,000 members (an increase of 4.0%) to 489,000.
CVS says its Board decided to enter the Australian marketplace because of its low levels of corporate consolidation, favourable market dynamics and strong similarities with the UK, including highly trained veterinary surgeons, shared language and culture, and the group's experience with UK vets working between Australia and the UK.
Earlier this month, the group signed agreements for the conditional acquisitions of four independent small animal first opinion veterinary practices in Australia: two in Brisbane, one in Queensland and one in Sydney, for an initial consideration of £16.8M.
Two of the acquisitions have now been completed, and the other two are expected to be completed shortly.
The company says it now plans to acquire more Australian practices in major urban conurbations, including Sydney, Melbourne, Brisbane, Perth, Canberra, Newcastle and Adelaide.
Ben Jacklin, Deputy CEO said: "Having worked as a vet in Australia earlier in my career, I know well their high standards of clinical care, and the dedication of highly talented veterinary professionals that work there.
"As a company dedicated to giving the best possible care to animals, I see a fantastic opportunity for us to enter this growing market, with low levels of corporate consolidation, and execute our vision of being the veterinary company people most want to work for.
"I have spent time in Australia over the last 12 months, including meeting some fantastic veterinary practices, and it is clear we have a significant opportunity.
"With the four outstanding practices that are joining us, and a strong pipeline of further acquisition opportunities, I am excited to build a significant CVS business in Australia with the same culture and values that have brought us success in the UK."
They say that dogs which lose sensation following damage to the spinal cord from a slipped disc have a prognosis for recovery of about 50%.
However, there is no reliable way of determining which dog will recover and failing that, owners must wait weeks to months to see if there are any signs of recovery, during which time dogs may need anaesthesia, surgery, and intensive nursing care.
The researchers say that the stiffness of an organ can be a marker of how damaged it is.
So, for the research, a new ultrasound machine equipped with an advanced piece of software (known as ‘shear wave elastography’) – will be used to measure the stiffness of a dog’s spinal cord during surgery.
The dog’s recovery to walking after surgery will then be monitored routinely.
The results will allow researchers to see if a relationship between spinal cord stiffness at time of surgery and recovery exists.
If successful, this would help them provide a more accurate prognosis for dogs with spinal cord injury in the future.
If you have a case suitable for this study, CVS says they will receive a gold standard treatment for spinal cord injury, which will include spinal surgery.
They will also have an ultrasound of the spinal cord performed during surgery, a procedure taking approximately 15 minutes.
Contact referrals@highcroftvet.co.uk or nicolas.granger@bristolvetspecialists.co.uk.
BVS Neurology study from CVS (UK) Ltd on Vimeo.
SPVS is leading a ground-breaking new project which aims to find out how veterinary surgeons are treating a range of clinical conditions.
Two hundred practitioners are being sought to provide details of how they address clinical conditions in three study areas: small animal, equine and farm animal, on a new website: www.howdoido.org. The findings, which will be made anonymous, will eventually form the basis of a clinical benchmarking process, which will tie in with the growing trend towards evidence-based medicine.
SPVS's objective is to understand and support how clinicians work in practice and approach particular clinical cases. The Society is working alongside Dr Mark Johnson who carried out the Confidential Enquiry into Perioperative Equine Fatalities.
SPVS Junior Vice President Jacqui Molyneux said: "This is an exciting new study which will shed a lot of light on what we as clinicians are doing in practice with the eventual aim of developing a clinical benchmarking process.
"The project however will only be worthwhile if a significant number of practitioners take part, so we're encouraging vets to visit the website and find out more. It will take no longer than ten minutes to fill in each clinical case."
Sanofi-aventis has signed an agreement under which it will buy Merck & Co Ltd's 50% stake in Merial Limited for $4 billion cash, after which it will own Merial outright.
According to the Wall Street Journal, Merck is selling its stake in Merial to avoid concerns from antitrust regulators that its pending acquisition of Schering-Plough will make it too dominant.
Merck, sanofi-aventis and Schering-Plough have also announced another agreement under which sanofi-aventis will have the option to combine Merck's Intervet/Schering-Plough Animal Health business with Merial to form an animal health joint venture owned equally by Merck and sanofi-aventis.
I thought Merial-Intervet-Schering-Plough was a bit of a mouthful, but sanofi-aventis-Merial-Intervet/Schering-Plough? The receptionist is going to have her work cut out.
Intervet/Schering-Plough Animal Health has announced the launch of PORCILIS AR-T DF, an inactivated vaccine against progressive atrophic rhinitis in piglets with a new adjuvant which the company says is associated with fewer injection site reactions.
PORCILIS AR-T DF uses DILUVAC FORTE (DF), an aqueous vitamin E-based adjuvant and will replace PORCILIS AR-T, a similar vaccine containing an oil-based adjuvant. The newly formulated vaccine is approved to reduce the clinical signs of progressive atrophic rhinitis in their offspring. Progressive atrophic rhinitis is caused by a toxin from the bacteria Pasteurella multocida affecting bone-forming cells in the snout of the young piglet.
Marc Dickie, Senior Director, Global Swine Business Unit at Intervet/Schering-Plough Animal Health said: "The innovative PORCILIS AR-T DF vaccine combines the proven efficacy of the current PORCILIS AR-T with an improved safety profile and convenience for the veterinarian that is offered by the aqueous DILUVAC FORTE adjuvant. The new vaccine also demonstrates the commitment of our company to continuously improve our vaccines, thereby offering value-added benefits to our customers."
The clinic will assess cats and dogs under six months old where a heart murmur has been detected.
Willows will then recommend a course of action and, if required, carry out keyhole surgery.
Chris Linney, head of cardiology at Willows, said: "This is the first specialist-led, congenital heart disease clinic in the country and will use some of the latest and most advanced equipment available in the veterinary world. As well as advanced ultrasound, we also have state-of-the-art CT available for assessment of complex cases.
"With the support of the 24/7 hospital service and other specialist disciplines here at Willows, it means we can offer excellent care to our patients, their owners and referring vets.
"All young animals with murmurs may benefit from the clinic, but those that are always recommended to undergo assessment are puppies with murmurs grade three (out of six) and over, and kittens with murmurs grade four (out of six) and over.
"By reviewing these animals at a younger age, we hope to be able to put care plans in place that can improve their long-term health.
"We will also offer a precise diagnosis, outlook and prognosis on the cause of the heart murmur and, where needed, carry out minimally-invasive keyhole surgery.
"Often, the earlier these are performed the better the outlook for the patient."
For more information, visit www.willows.uk.net.
532 veterinary practices responded to the survey, which was sent to 3,096 veterinary practices for which the RCVS had a unique email address, on 3rd April.
The survey found that:
Three-quarters of those who responded to the survey answered a question on how the RCVS could better support veterinary practices through the crisis. The most frequent response (27%) was that the RCVS needed to provide clearer guidance, in particular as to what services it was permissible for veterinary practices to provide [the College published its updated guidance and flowchart on 9 April].
Of those who responded to the question, 15% felt that the RCVS was doing a good job or that there was nothing more it should do, while just 2% of responses expressed negative sentiment towards the RCVS.
Lizzie Lockett, RCVS Chief Executive, said: “I would like to thank all those practices who took the time in what is already a very fraught situation to respond to our survey and provide the evidence we need to gain a holistic picture of coronavirus’ impact on the business and economics of veterinary practices. We plan to continue running these surveys on a regular basis in order to gauge impact over time and the findings will feed into our policy and decision-making.
"This ongoing research will also be a vital tool when we are talking to Government and other bodies about the impact of policy on the veterinary sector. On this note, we are aware of the challenges of a minimum furlough period of three weeks given the need for practices to take steps to offer 24/7 emergency and critical care, and have written to government on this with some case studies around the impact this is having.
"To those on the ground it won’t come as too much of a surprise that the impact of the coronavirus has been profound in areas such as practice turnover and staffing, with many vets, veterinary nurses and other support staff being furloughed with the aim of signing them up to the Government’s Coronavirus Job Retention Scheme.
"There are some bright spots in the data we’ve gathered – very few practices reported that they had made or were planning to make staff redundant, and many practices reported mitigating the challenge of social distancing by carrying out consultations with new and existing clients remotely.
"Since the survey took place we have also taken steps to meet some of the requests for greater clarity and guidance from the RCVS with the publication of our flowchart helping practices to decide what treatments it is appropriate to carry out safely amidst the COVID-19 pandemic."
The survey results can be read in full at www.rcvs.org.uk/publications.
The next practice impact survey is planned for early May.
Under the new policy, introduced this month, women who joined the company more than two years ago are entitled to six month's maternity leave on full pay, while those who have been with the company for less than that are entitled to three months at full pay and three months at half pay.
After six months, statutory rates will be paid.
Meanwhile, new fathers are now entitled to four week's paternity leave on full pay.
Mark Ross (pictured right), CEO of Vets Now, said: “Several staff wrote to me about this issue and I agreed to look into it.
"Our previous maternity policy was six weeks full pay, six weeks half pay, followed by statutory rates, while men received 1.5 weeks of full paternity pay, so this is a huge leap forward. The changes cover maternity leave, shared parental leave, adoption and surrogacy.
"Our business has been tremendously successful in the past few years, thanks to the incredible hard work of our people, and we’re always looking at innovative ways of reinvesting our profits back into the business so it’s our people who benefit most.
"We’re also hoping to put in place other improvements and among the initiatives we’re looking at are providing better support for staff returning to work after a period of leave, better provisions for nursing mums, a dedicated resource for parents who are struggling, and additional leave during the first year of returning to work.
"We want to make Vets Now a great place to work for all of our staff, no matter what stage they’re at in life."
The website, web-vetneurology.com, has an open access veterinary neurology literature section with up-to-date research on all aspects of neurological diagnosis and treatment.
The website also includes a case study section showing video footage and cross-sectional imaging studies of interesting and illustrative cases.
New, common and rare cases of clinical neurology presentations seen in cats and dogs are added every month.
There's also a range of webinars and podcasts.
The first podcast series - Neurology for Vets and Pets – aims to demystify veterinary neurology in small ‘bite-sized’ episodes, aiming to keep vets up to date on how to diagnose and treat the most common problems in practice and the clinical signs they will see in their cat and dog patients.
The second - Neurology for Specialists - is for vets who have a special interest in neurology, looking at the most challenging neurological problems in dogs and cats, and focusing on the latest publications - often presented by the authors of these studies.
Laurent Garosi said: “The reason behind this website is purely altruistic. We share a passion for neurology and - like the launch of our earlier Facebook page – we wanted to use this platform to share the fifty-plus combined years of experience we have between us.
“We do hope that we have created a comprehensive source of veterinary education and that it will act as an invaluable veterinary neurology resource for vets around the globe for many years to come.”
The website has been developed and supported by PRN Pharmacal in the United States.
Isle of Wight based veterinary surgeon Dan Forster has had his mobile practice named as the best Business to Consumer Start-up at the inaugural Ready for Business Awards 2013.
Dan launched The Mobile Vet in June 2013, since when he has treated patients from across the Isle of Wight and allowed members of the community who may have been unable to take their pets to the vets for years due to illness or age-related conditions access care for their animals. He says his service has also reactivated many dormant patients who had not visited a vet for many years and had fallen behind with vaccinations, plus those who had decided not to visit because their pets were too nervous or aggressive. Apparently, the service has also gone down well with busy families and households with multiple pets.
The judging panel included David Hitchcock of Barclays, Amanda Hurford from the Department for Business, Innovation and Skills and Titus Sharpe, chief executive of MVF Global and winner of the Sunday Times Tech Track 2013. They selected The Mobile Vet as the winner due to its innovative approach whilst still offering all the traditional veterinary services its customers require. The judges were also impressed by its potential for growth, not just in the South East, but possibly throughout the UK and its drive to continually invest in the latest equipment and create additional job opportunities.
Dan said: "We are truly delighted to have our achievements recognised with such a prestigious accolade so soon after launching The Mobile Vet. The help we received to get started and the on-going support available to us has made it possible to develop our idea into a thriving business operation and we now look forward to pushing ahead with our plans for the future."
Kevin Horne, chairman of the Cavendish Consortium added: "In what was a highly competitive category, The Mobile Vet stood out as offering a very difference proposition to its customers and demonstrated a clear understanding of the needs of its clients. We were impressed by the drive and determination shown by Dan and his colleagues to make what is an extremely novel idea a business reality and wish them, and all the other worthy finalists, well as they strive forward."
Melissa graduated from the University of Glasgow in 1987 and, after working as a food animal intern at Iowa State University in the United States for a stint, in 1990 joined a two-person traditional mixed-animal veterinary practice on the Ayrshire coast. Over the next 25 years she developed it into a 4.5 person small-animal practice with a focus on dentistry, before moving away from clinical work in 2015.
Melissa was first elected to Council in 2016 and re-elected in 2020 and, since joining, has sat on a number of committees including the Education Committee, Finance & Resources Committee, and Preliminary Investigation Committee/Disciplinary Committee Liaison Committee. Since 2019 she has chaired the Standards Committee where she has led the Review of ‘Under Care’ and Out-of-Hours Emergency Cover and also chairs the Certificate in Advanced Veterinary Practice Subcommittee.
As well as her work with RCVS she has also been President of the British Veterinary Association’s Scottish Branch and is currently a Non-Executive Director of the Red Tractor Assured Food Standards Scheme and a Trustee of the Scottish Society for the Prevention of Cruelty to Animals. Outside of work, she enjoys running, swimming, cooking, reading and hopes to have the patience one day to write children’s books.
Melissa said: “I’m delighted and humbled to have been voted in as JVP from July. Thank you to my peers on Council and, as with everything I have done in my career, you, the profession, will see me put all my energy and commitment into the role.
"Themes that I'm keen to develop as a member of the RCVS Officer Team will be: communication, as that can always be improved; community, including within the profession, within the workplace and within the society in which you live; and continuing with the ‘blame culture’ theme originally set out in Chris Tufnell's presidency by looking into how we can use veterinary human factors to improve patient safety."
Other appointments that were confirmed by election at the same meeting of Council was Dr Niall Connell MRCVS as RCVS Treasurer, a role he will take up at the July AGM after completing his year as Senior Vice-President.
Niall: “It is a tremendous honour for me to be elected Treasurer. The RCVS has an exciting strategy which I am looking forward to playing my part in ensuring we remain on a sound financial footing, supporting projects within the RCVS Strategic Plan and continuing to play a wider role within the RCVS Officer Team.”
In terms of committee chairs, Dr Sue Paterson FRCVS was reconfirmed as Chair of the Education Committee, Dr Melissa Donald was reconfirmed as Chair of the Standards Committee and current RCVS President Dr Mandisa Greene MRCVS was elected as Chair of the Advancement of the Professions Committee, replacing Professor David Argyle in that post from July 2021.
Following Professor Argyle stepping down as Junior Vice-President earlier in March 2021, an election to replace him as Junior Vice-President for the remainder of the presidential year will take place in April 2021. Subject to the usual approval from Council, this person will take up the position of RCVS President 2021-22 following the AGM in July.
The RCVS Disciplinary Committee has restored Joseph Lennox Holmes to the Register of Veterinary Surgeons, two years after he was originally struck off.
Mr Holmes was removed from the Register in February 2012 after the Disciplinary Committee found him guilty of multiple charges of serious professional conduct. Mr Holmes lodged an appeal against the decision, which was heard and dismissed by the Privy Council.
The original charges related to two separate complaints; the first involved numerous charges in respect of Mr Holmes' treatment of a King Charles Spaniel between October 2007 and March 2008; the second, several charges in relation to his treatment of three cats in 2008.
The Committee found that the majority of the charges amounted to serious professional misconduct. In removing Mr Holmes from the Register, the Committee found that "aggravating factors in both... cases included actual injuries to the animals... and a serious breach of the trust which Mr Holmes' clients had placed in him to make the welfare of the animals his primary consideration according to the standards to be expected of the profession". In addition, the Committee cited 10 further aggravating factors including lack of reference to continuing professional development (CPD) in clinical policies and practices; lack of reference to accepted practice; lack of appreciation of the importance of adequate pain relief when performing painful surgical procedures; reluctance to consider referral as an option; and lack of understanding about what information is required by a client to enable fully informed consent to be given.
Following the dismissal of Mr Holmes' appeal by the Privy Council, his first application for restoration was heard by the Disciplinary Committee in February 2013. The Committee was not satisfied that he was fit to be restored to the Register, citing the fact that his application was "premature" and that he had failed to truly appreciate the seriousness of the findings against him. The Committee was also unimpressed with the efforts he had made to keep up-to-date with skills and developments in practice and with his CPD, noting in particular that he had made very limited attempts to observe the function and experience the culture of a modern first opinion practice.
However, in this week's two-day hearing, the Committee was satisfied that Mr Holmes was now fit to be restored to the Register. It heard that Mr Holmes had made a concerted effort to engage in CPD and bring his skills and knowledge up-to-date. During a period of observation at a veterinary practice, he had gained insight into modern practice and the need for veterinary general practitioners to be aware of the advantages in referring patients to specialists.
Professor Noreen Burrows, who chaired and spoke on behalf of the Disciplinary Committee, said: "The Committee has concluded that, in the course of genuine efforts to do what was necessary to address the deficiencies identified during the original Inquiry and at the last restoration hearing, the Applicant has at last understood the seriousness of his previous misconduct and has learned new skills and, most importantly, to recognise his limitations from the extensive course of study, reflection, and other training that he has undertaken."
Furthermore, the Committee was satisfied that Mr Holmes had gained a proper understanding of the importance of securing the informed consent of his clients and building a relationship of trust with them and, in addition, recognising the importance of maintaining close relations with fellow professionals and engaging with CPD opportunities.
Additional factors considered when making the decision included: that he had been off the Register for two years; that, through self-improvement, he had equipped himself to treat animals appropriately; the impact that being removed from the Register had in both personal and financial terms; his conduct since being removed from the Register; and, a number of positive testimonials from previous clients and professional colleagues.
The Committee's full findings and decision are available on the RCVS website (www.rcvs.org.uk/disciplinary).
Elanco Animal Health has announced the launch of Osurnia, a new treatment which it says will drive compliance when treating canine otitis externa infections.
According to the company, compliance with daily ear drops has been shown to be poor, with up to 80% of owners administering the incorrect dose to their pet. The most common reason for a lack of compliance is the difficultly in applying the drops1.
Elanco says that Osurnia has the potential to improve compliance in treating otitis externa significantly, because unlike other medications which require 5-28 doses during the course of treatment2, Osurnia only needs two-doses given a week apart.
Osurnia contains a gel formulation of three active ingredients including the antibiotic florfenicol, which is new to companion animal treatment in the UK, terbinafine, which inhibits the growth of yeast as demonstrated for Malassezia spp., and the glucocorticosteroid, betamethasone acetate, to help relieve discomfort.
Osurnia is administered in a pre-measured, single-dose tube designed to ensure the right dose every time. It has a flexible, soft tip designed to make treatment with Osurnia a comfortable experience for the dog. The gel formulation squeezes out of the tube and spreads through the ear, adhering inside the ear canal for long-lasting action. The dose is the same for any dog, regardless of size and weight.
Alice Laurens, DVM MRCVS, dermatology marketing manager at Elanco Animal Health said: “Otitis externa is a common challenge for both vets and clients, with ear infections among the ten most frequent reasons for dogs to be presented with vets, affecting up to 20% of dogs3.
“Osurnia is an innovative, effective treatment that is administered in just two doses ensuring it is much more convenient for pet owners thereby increasing the likelihood that they will complete the entire treatment schedule leading to more comfortable dogs and peace of mind for owners.”
Elanco has produced a client leaflet on treating otitis externa with Osurnia. For further information, or to order client leaflets, please contact your local Elanco Animal Health Territory Manager or email elancoCAH.uk@elanco.com.
References
Fort Dodge Animal Health has announced that its Zulvac 8 Ovis® Bluetongue sheep vaccine is now licensed and available in the UK. The company believes that the product will provide significant benefits to sheep farmers.
Zulvac 8 Ovis® is an inactivated adjuvanted vaccine for the active immunisation of sheep by subcutaneous injection against Bluetongue Serotype 8. It also provides a reduction in viraemia. Administration is a two x 2 ml dose primary course in year one but only a single shot booster in the second year.
The use of Zulvac 8 Ovis as a booster for animals previously vaccinated with a primary course from other manufacturers is in line with Defra (2009) guidance: 'No problems are anticipated with re-vaccinating animals which have already received a primary course of vaccination with a different vaccine 1'.
The first dose can be administered from one month of age and Zulvac 8 Ovis® is proven for use in pregnant sheep. The onset of immunity is provided 25 days after the second dose.
Fort Dodge says Zulvac provides cost savings to farmers through its pricing strategy. While the price for the two dose primary course is competitive with alternative vaccines, for animals which were vaccinated last year and require only a single shot booster, the cost will be half that of competitive offerings, providing a significant incentive to farmers to vaccinate.
The vaccine is supported by a specific Zulvac Ovis fixed 2ml dose applicator with Sterimatic needle protector and cleaning system which aids administration and hygiene and is sold separately.
David Bartram MRCVS, Veterinary Technical Manager at Fort Dodge, said: "Sheep farmers have been waiting for a Bluetongue vaccine which offers a cost effective solution to vaccination - particularly for animals which received their primary course last year and are simply in need of a booster. We expect the fact that it's licensed for use in pregnant sheep to also prove attractive.
"Zulvac 8 Ovis® is the latest addition to Fort Dodge's Zulvac range for both cows and sheep. It is already used in Europe and has helped protect millions of animals."
Virbac, maker of Pronefra for the management of CKD in cats and dogs, has launched a free app to help interpret patients' urine test results in line with the latest International Renal Interest Society (IRIS) Guidelines.
The app, which is also called Pronefra, is available for download on both the Play store and Apple store.
Simon Boulton MRCVS, Marketing Manager for Companion Animals, said: "Reference ranges supplied by machines and labs are not always appropriate for the renal patient so we wanted to help practices to interpret kidney-specific results quickly and easily in line with the latest recommendations. The Pronefra app was the result. We have received very positive feedback on the app so far and hope it will help practices improve the quality and length of life of their renal patients."
Virbac is also providing further Pronefra practice support materials, include a pet health recording book for clients to aid in compliance and other educational tools for vets, nurses and clients.
The following batches are affected:
Dechra is contacting wholesale dealers and asking practices to examine inventory immediately and quarantine products subject to this recall.
For further information contact Ms Carol Morgan: carol.morgan@dechra.com .
MSD says that no other UK-licensed BRD vaccine can be administered earlier in life and that the onset of immunity for BRSV is 6 days (for calves vaccinated from the day of birth onwards) and 5 days (for calves vaccinated from the age of one week onwards).
Onset of immunity for Pi3V is one week after vaccination. The duration of immunity is 12 weeks for both viruses.
From a practical standpoint, the new license means Bovilis Intranasal RSP Live can now be used on farm at the same time as other early life interventions associated with newborn calves – for example, colostrum/first milk feeding, navel management, tagging, jacketing and necessary pen movements.
Additionally, Bovilis Intranasal RSP Live can be used up to six hours after mixing with the solvent, which MSD says is the longest of all the available intranasal vaccines for these pathogens.
The vaccine is supplied as a nasal suspension product that doesn’t need a specific applicator – although for maximum flexibility an easy-clean injector and nozzle kit is available for vaccinating multiple animals.
The vaccine is available in 5x1 dose, 5 dose and 5x5 dose packs.
The webinar will be presented by Marge Chandler DVM, MS, MANZCVS, DACVIM (SAIM, Nutrition), MRCVS and Dr Michael Lappin DVM, PhD, DACVIM.
Marge is an independent consultant in small animal nutrition and internal medicine and Chair of the FEDIAF Scientific Advisory Committee, founding member of the European Veterinary Nutrition Educators Group, and Co-Chair of the WSAVA Global Nutrition Committee.
Michael is the Kenneth W. Smith Professor in Small Animal Clinical Veterinary Medicine and Director of the Center for Companion Animal Studies at Colorado State University. He is on the editorial board of Feline Medicine and Surgery and Compendium on Continuing Education for the Practicing Veterinarian and is the editor of the textbook, Feline Internal Medicine Secrets.
The webinar will discuss the value supplements can offer to pets who are already on complete diets, how supplements are regulated and the importance of quality control.
The session will also cover the challenges for vets in selecting supplements for their clinical practice, what factors can determine the choice of supplement, and how you can critically evaluate the evidence supporting a supplement.
Marge and Michael will also provide tips for communicating the benefits of supplements to clients.
Daniel Rodes Moltó of the Purina Institute said: “We are pleased to offer this interactive webinar on how to evaluate and select supplements using an evidence-based approach in a non-promotional setting.
"Webinar attendees are welcome to submit questions for our speakers in advance and to ask questions during the live event, which promises to be an enjoyable and lively session supporting the aim of improving the lives of pets.”
https://webapp.spotme.com/login/eventspace/CollaborativeCareMay2023
Fourth year veterinary students from the University of Sydney's Faculty of Veterinary Science have produced a nude calendar in which they use a variety of strategically placed animals to protect their modesty.
The calendar, called Under the Overalls, features a variety of animals, including three lucky (depending on your point of view) llamas, a calf, three sheep and a rather unfortunate fish.
It's all in aid of charity. For more information, visit https://www.facebook.com/undertheoveralls, or you can buy the calendar for $20 at www.undertheoveralls.com.
Picture: House of Cameo
The outreach programme began earlier this month at the Devon County Show (pictured right), where the College used the opportunity to spread the word about its petsneedvets campaign, handing out over 1000 promotional bags in the process.
Next on the itinerary is the Royal Welsh Show near Builth Wells from the 23rd to 26th July. From there, the College will be heading to the BBC Countryfile Live event, held in the grounds of Blenheim Palace in Oxfordshire from the 2nd to 5th August.
Ian Holloway, Director of Communications at the RCVS, said: "Following the success and popularity of our stand at Countryfile Live over the past two years we decided that this year we would broaden our horizons and attend some of the UK’s most prestigious and well-attended regional events.
"We have our ever-popular careers materials available, and it was wonderful to see dozens of young people at the Devon County Show asking us about how they can become veterinary surgeons and veterinary nurses, as they always have the past two years at Countryfile. This is a really encouraging level of interest in the professions and we’re very happy to provide information to help them fulfil their aspirations.
"Attending more and different public events is a trend we are very keen on continuing with and we will be looking at other events to attend in different parts of the UK for next year."
For more information about upcoming events involving the RCVS visit www.rcvs.org.uk/events
Photo: Royal College of Veterinary Surgeons
Pfizer Animal Health has launched Poulvac, the first modified live vaccine against E.coli in chickens.
The company claims that the vaccine, which can be used from one day of age, is set to bring major benefits in safeguarding the health of broilers, pullets for egg laying and breeding stock.
According to Pfizer, E.coli is one of the most significant bacterial pathogens found in chicks during the first week, leading to problems throughout the life of a flock including inferior performance, lack of uniformity and increased mortality. It is a costly, widespread problem for the UK poultry industry.
The vaccine was developed from research beginning in the 1990s at the Government's veterinary laboratories at Weybridge (now AHVLA) in the UK, employing genome technology to produce an avirulent strain of E.coli that induces protective immunity to the pathogenic strains of the bacteria.
The vaccine is completely non-pathogenic, and does not persist in the bird or the environment for any significant period of time. A gene deletion in its development restricts in vivo replication and leaves behind activated macrophages ready to respond to pathogenic E.coli strains.
Dr Stuart Andrews, poultry technical manager of Pfizer in the UK and Ireland said: "Poulvac E. coli provides broad cross protection against the key serotypes of E. coli infecting chickens. It is the only modified live, nonreactive vaccine proven to meet the European regulatory requirements for efficacy and safety.
"Trials have confirmed that Poulvac E.coli does not persist in the bird and proves to be self-limiting. The vaccine can survive in the environment for only a short time, and spread to in-contact birds is also limited."
The vaccine is administered as a coarse spray with onset of immunity 14 days afterwards and duration of immunity for up to 12 weeks. It can be used from day-old up to six weeks before the onset of lay, and has a nil day withdrawal period.
In the USA where Poulvac E coli has been available for six years field experience has shown the considerable benefits. In the Midwest where average layer mortality at 50 weeks of age was 2.31 per cent, this was reduced to 1.51 per cent with three doses of the vaccine*. In Eastern USA flock mortality compared with five previous flocks was reduced from over three per cent to one per cent.
A field trial in the USA with more than 300,000 broiler breeders vaccination before lay reduced mortality from 2.8 to 1.9 per cent - with only two out of 28 flocks needing antibiotic treatment compared with 13 of the 28 unvaccinated flocks.
On a broiler field trial in Georgia over four million birds were vaccinated with Poulvac E. coli at hatch. The vaccinated birds had a better feed conversion (1.79 against 1.84 for the controls) and with condemnations at the processing plant down from 1.22 to 0.73 per cent the result was a lower production cost of 0.51¢ per lb.
In another broiler trial covering more than two million birds in Arkansas livability was improved from 95.20 to 95.77 per cent and feed conversion improved from 1.95 to 1.90, gaining 0.45¢ per lb.
* Pfizer says it is important to note that in these studies carried out in the USA more than one dose of the vaccine was often administered. A single vaccination is licensed in the Summary of Product Characteristics however, where clinical disease requires and at the discretion of a veterinary surgeon, the vaccination schedule may be re-started as there is no contra-indication on the SPC.